Circ‐RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR ‐140‐5p

A novel circular RNA circFN1 enhances cisplatin resistance in gastric cancer via sponging miR‐182‐5p

(2020) Xiao‐xu Huang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Long noncoding RNA SNHG16 induces sorafenib resistance in hepatocellular carcinoma cells through sponging miR-140-5p

(2019) Junfeng Ye et al.   OncoTargets and Therapy

circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer

(2019) Yuting Sang et al.   MOLECULAR THERAPY

Analysis of miRNA–mRNA network reveals miR-140-5p as a suppressor of breast cancer glycolysis via targeting GLUT1

(2019) Yunjie He et al.   Epigenomics

ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer

(2019) Marco La Ferla et al.   Frontiers in Oncology

circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer

(2019) Yiran Liang et al.   ONCOGENE

Circular RNAs function as ceRNAs to regulate and control human cancer progression

(2018) Yaxian Zhong et al.   Molecular Cancer

Knockdown of Linc00515 Inhibits Multiple Myeloma Autophagy and Chemoresistance by Upregulating miR-140-5p and Downregulating ATG14

(2018) Daifeng Lu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Circular RNA EIF6 (Hsa_circ_0060060) sponges miR-144-3p to promote the cisplatin-resistance of human thyroid carcinoma cells by autophagy regulation

(2018) Feng Liu et al.   Aging-US

Three Combined Treatments, a Novel HDAC Inhibitor OBP-801/YM753, 5-Fluorouracil, and Paclitaxel, Induce G2 Phase Arrest Through the p38 Pathway in Human Ovarian Cancer Cells

(2017) Makoto Akiyama et al.   ONCOLOGY RESEARCH

Screening circular RNA related to chemotherapeutic resistance in breast cancer

(2017) Danfeng Gao et al.   Epigenomics

MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy

(2017) Yichen Meng et al.   Scientific Reports

Circular RNAs are miRNA sponges and can be used as a new class of biomarker

(2016) Franceli Rodrigues Kulcheski et al.   JOURNAL OF BIOTECHNOLOGY

Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells

(2015) Karolina Weiner-Gorzel et al.   Cancer Medicine

MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer

(2014) Wen-Dong Bai et al.   INTERNATIONAL JOURNAL OF CANCER

miR-203 sensitizes glioma cells to temozolomide and inhibits glioma cell invasion by targeting E2F3

(2014) GUODONG TANG et al.   Molecular Medicine Reports

MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2)

(2013) Meng-Tao Ma et al.   CANCER LETTERS

Circular RNAs: splicing’s enigma variations

(2013) Matthias W Hentze et al.   EMBO JOURNAL

MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3

(2011) Bing Feng et al.   CANCER

Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism

(2011) Y. Zhao et al.   CANCER RESEARCH

Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib

(2009) Henk J. Broxterman et al.   DRUG RESISTANCE UPDATES

The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation

(2008) Ralph J. DeBerardinis et al.   Cell Metabolism

Conserved functions of the pRB and E2F families

(2008) Sander van den Heuvel et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY